REGENERX

RegeneRx is a virtual biopharmaceutical company focused on tissue protection, repair and regeneration. While historically developing novel pharmaceuticals that protect and repair tissue and organ damage caused by disease, trauma or other pathology, the Company's primary focus is on Thymosin beta 4 (Tβ4) to treat ophthalmic indications such as neurotrophic keratitis (NK) and dry eye disease (DED).

Also known as: RegeneRx Biopharmaceuticals, Inc.